BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2014
View Archived Issues
TaiGen Biotechnology presents phase III data for oral nemonoxacin
Read More
Clinical efficacy and safety of a novel antiretroviral drug for HIV infection
Read More
Neurocrine Biosciences begins trial of NBI-98854 in Tourette syndrome
Read More
Sorrento Therapeutics outlicenses Chinese rights to anti-PD-L1 antibody
Read More
Novartis and BMS collaborate on trials of anticancer immunotherapy combinations
Read More
DecImmune Therapeutics awarded SBIR grant to support DeciMab studies
Read More
Oryzon Genomics patents novel DDR1 antibodies for cancer
Read More
Researchers at Agios Pharmaceuticals patent novel agents for cancer and anemia
Read More
Novel agents investigated for fibrosis
Read More
Galapagos describes discovery of FFA2 antagonist in development for ulcerative colitis
Read More
Actavis and Durata Therapeutics enter merger agreement
Read More
Cell Cure Neurosciences files IND with the FDA for OpRegen
Read More
New PDE10A inhibitors patented by Merck & Co.
Read More
BMS and MD Anderson Cancer Center form immuno-oncology collaboration
Read More
Alcobra reports topline results from phase III study of metadoxine in adults with ADHD
Read More
Canadian group synthesizes novel PCSK9 inhibitors for LDL-C
Read More
Sunesis Pharmaceuticals reports data from pivotal phase III VALOR trial
Read More
Chimerix confirms emergency IND application for brincidofovir for Ebola
Read More
Capricor Therapeutics to advance CAP-1002 for Duchenne muscular dystrophy
Read More
Early clinical results for KRN-23 as potential treatment of X-linked hypophosphatemia
Read More
Perosphere signs new trial agreement with Daiichi Sankyo to study PER-977
Read More
Medac Pharma launches Rasuvo in U.S.
Read More
Acacia Pharma reports phase III data for APD-421 in post-operative nausea and vomiting
Read More
FDA expands approval for Eylea Injection in treating macular edema following retinal vein occlusion
Read More
Novel selective prostanoid EP2 receptor agonist shows promise in preclinical studies
Read More
